VOYA Investment Management’s Arcturus Therapeutics ARCT Stock Holding History

VOYA Investment Management’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7,710	Closed	-$260K	–	2828
2024 Q1	$260K	Sell	7,710 -1,768	-19%	-$62.6K	﹤0.01%	2324
2023 Q4	$299K	Buy	9,478 +183	+2%	+$4.35K	﹤0.01%	2350
2023 Q3	$237K	Hold	9,295	–	–	﹤0.01%	2441
2023 Q2	$267K	Buy	9,295 +447	+5%	+$12.2K	﹤0.01%	2436
2023 Q1	$212K	Buy	+8,848	New	+$159K	﹤0.01%	2502
2022 Q2	–	Sell	-8,282	Closed	-$223K	–	2774
2022 Q1	$223K	Hold	8,282	–	–	﹤0.01%	2313
2021 Q4	$307K	Sell	8,282 -19	-0.2%	-$774	﹤0.01%	2288
2021 Q3	$397K	Hold	8,301	–	–	﹤0.01%	2190
2021 Q2	$281K	Sell	8,301 -457	-5%	-$15.5K	﹤0.01%	2402
2021 Q1	$362K	Sell	8,758 -682	-7%	-$40.7K	﹤0.01%	2204
2020 Q4	$410K	Buy	9,440 +1,738	+23%	+$118K	﹤0.01%	2035
2020 Q3	$330K	Buy	7,702 +3,203	+71%	+$159K	﹤0.01%	1891
2020 Q2	$210K	Buy	+4,499	New	+$155K	﹤0.01%	2124

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VOYA Investment Management's ARCT Position: Q2 2024 in Review

VOYA Investment Management sold out of Arcturus Therapeutics (ARCT) in Q2 2024, closing a stake of 7,710 shares — an estimated $260K sold.

VOYA Investment Management first reported a position in ARCT in Q2 2020 and held it in 13 quarters. The position peaked at $410K in Q4 2020. 171 funds tracked by Wall St. Rank hold ARCT as of Q2 2024.

VOYA Investment Management reported no remaining Arcturus Therapeutics position as of Q2 2024 after selling out during the quarter.
VOYA Investment Management sold 7,710 Arcturus Therapeutics shares in Q2 2024, an estimated $260K.
VOYA Investment Management first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 13 quarters.
VOYA Investment Management's Arcturus Therapeutics position peaked at $410K in Q4 2020.
171 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.